Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

Table 2

The distribution of the genotypes in COVID-19 and control groups.

Genotype	COVID-19 group	Control group		value
DD	45 (40%)	77 (26%)	46.6	<0.00001
DI	59 (53%)	95 (32%)
II	8 (7%)	128 (42%)
Allele
D	149 (67%)	249 (42%)	40.9	<0.00001
I	75 (33%)	351 (58%)

Control frequencies were obtained from literature on Turkish population [13].